Germany’s Cannabis Legalization: Progress, Problems, and Uncertainty

Two years after the partial legalization of cannabis, the results in Germany are mixed. While the market for medical cannabis is booming and millions of consumers are legally allowed to consume it for the first time, cannabis social clubs continue to struggle with massive bureaucracy, slow approval processes, and political uncertainties.

The big question now is:
Has legalization actually achieved its most important goals?
The black market still exists.

One of the central goals of the cannabis reform was to curb the illegal trade. Initial developments show that legal sources are slowly gaining importance. However, the black market remains active.Particularly problematic:

In many regions of Germany, functioning cannabis social clubs still do not exist. As a result, numerous consumers continue to resort to illegal providers. Security authorities also report that while the black market has come under pressure, it has by no means disappeared.
Cannabis social clubs are struggling with bureaucracy.

The situation of growers’ associations, in particular, is causing increasing frustration. Many clubs report the following:

long waiting times
complicated application procedures
Different rules apply in each federal state.
high demands
unclear responsibilities of authorities

Numerous clubs are still waiting for final approvals or are struggling with bureaucratic hurdles in their day-to-day operations.Many operators now feel more like administrative companies than like community cannabis associations.

Medical cannabis is growing rapidly

While the clubs are having problems, another area is developing all the more dynamically: medical cannabis. Germany has now become the largest medical cannabis market in Europe. The number of patients is constantly rising, international companies are investing heavily, and telemedicine platforms are growing rapidly.

Above all:

Online prescriptions
Cannabis telemedicine
international imports
new pharmacy models

have drastically changed the market.However, critics are increasingly warning against the commercialization of the system. In some cases, the impression arises that medical cannabis is significantly more easily accessible than regulated recreational use.

Politics remains uncertain

Additional uncertainty arises from the political debate in Germany. Several parties are already calling for improvements or restrictions to the cannabis law. Topics under discussion include:

stricter rules for telemedicine
Shipping restrictions
stricter controls
Adjustments to the Social Clubs

The industry fears this will lead to a lack of planning certainty and investment barriers.
Europe is watching Germany closely.

Despite all the problems, Germany remains the most important cannabis experiment in Europe.Many European states are watching closely:

the development of social clubs
the impact on the black market
economic effects
health policy consequences
the handling of medicinal cannabis

Countries like the Czech Republic, Luxembourg, and Switzerland, in particular, are partly orienting themselves towards the German model.
Legalization remains an ongoing experiment.

Two years after the reform, one thing is particularly clear:

Cannabis legalization is not a completed process, but a large-scale social experiment in progress.Some goals were achieved:

Decriminalization of many consumers
Building legal structures
Growth of the medical market
Other problems persist:
bureaucracy
black market
political uncertainty
missing commercial sales models

Germany thus remains in the midst of a historic period of upheaval in cannabis policy.And that is precisely why the debate about cannabis is likely to become more intense rather than calmer in the coming years.

__

(Featured image by Erik Mclean via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in HanfJournal. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.